PLZF and the Human Immune System
Author Information
Author(s): Eidson Maggie, Wahlstrom Justin, Beaulieu Aimee M., Zaidi Bushra, Carsons Steven E., Crow Peggy K., Yuan Jianda, Wolchok Jedd D., Horsthemke Bernhard, Wieczorek Dagmar, Sant'Angelo Derek B.
Primary Institution: Memorial Sloan-Kettering Cancer Center
Hypothesis
PLZF controls the development and function of various human lymphocyte populations.
Conclusion
PLZF is expressed in a greater variety of lymphocytes in humans compared to mice, and its expression significantly impacts immune cell development and function.
Supporting Evidence
- PLZF was found to be expressed in all γδ T cells and NK cells.
- More than 10% of human peripheral blood lymphocytes express PLZF.
- PLZF expression was altered in patients with autoimmune diseases and metastatic melanoma.
Takeaway
PLZF is a special protein that helps certain immune cells grow and work properly, and it does this in more types of cells in humans than in mice.
Methodology
The study involved blood samples from patients with autoimmune diseases and cancer, analyzed using flow cytometry and real-time PCR.
Potential Biases
Potential bias due to the unknown treatment status of patients and the limited diversity of the patient population.
Limitations
The study was limited by the small sample sizes of patient groups and the lack of selection criteria for patient samples.
Participant Demographics
Included patients with systemic lupus erythematosus, primary Sjögren's syndrome, metastatic melanoma, and healthy controls.
Statistical Information
P-Value
0.0080
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website